Inventor · disambiguated record
Peter Lewandrowski
Also filed as: LEWANDROWSKI PETER
33 granted patents·4 pending applications·729 citations·filing 2008–2024
98Inventor score
Files withIMMATICS BIOTECHNOLOGIES GMBH27FRITSCHE JENS3RAMMENSEE HANS GEORG3LEWANDROWSKI PETER2WEINSCHENK TONI2
Top patents by PatentIndex Score
37 records- 0199US11298404B2Immunotherapy against several tumors including gastrointestinal and gastric cancerIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Apr 12, 2022·14 cites·20 claims
- 0299US11273200B2Immunotherapy against several tumors including gastrointestinal and gastric cancerIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Mar 15, 2022·15 cites·20 claims
- 0399US11077171B2Immunotherapy against several tumors including gastrointestinal and gastric cancerIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Aug 3, 2021·18 cites·20 claims
- 0499US10933118B2Immunotherapy against several tumors including gastrointestinal and gastric cancerIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Mar 2, 2021·18 cites·20 claims
- 0599US10898546B2Immunotherapy against several tumors including gastrointestinal and gastric cancerIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jan 26, 2021·15 cites·20 claims
- 0699US10478471B2Immunotherapy against several tumors including gastrointestinal and gastric cancerIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Nov 19, 2019·13 cites·20 claims
- 0799US10420816B1Immunotherapy against several tumors including gastrointestinal and gastric cancerIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Sep 24, 2019·21 cites·20 claims
- 0899US10357540B2Immunotherapy against several tumors including gastrointestinal and gastric cancerIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Granted Jul 23, 2019·18 cites·15 claims
- 0999US9993523B2Immunotherapy against several tumors including gastrointestinal and gastric cancerIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Granted Jun 12, 2018·52 cites·14 claims
- 1099US9895415B2Immunotherapy against several tumors including gastrointestinal and gastric cancerIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Granted Feb 20, 2018·55 cites·14 claims
- 1199US9717774B2Immunotherapy against several tumors including gastrointestinal and gastric cancerIMMATICS BIOTECHNOLOGIES GMBH·Filed 2015·Granted Aug 1, 2017·63 cites·7 claims
- 1298US11648292B2Immunotherapy against several tumors including gastrointestinal and gastric cancerIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted May 16, 2023·2 cites·20 claims
- 1398US10905741B2Immunotherapy against several tumors including gastrointestinal and gastric cancerIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Feb 2, 2021·10 cites·20 claims
- 1498US10064913B2Immunotherapy against several tumors including gastrointestinal and gastric cancerWEINSCHENK TONI·Filed 2011·Granted Sep 4, 2018·37 cites·18 claims
- 1598US9101585B2Immunotherapy against several tumors including gastrointestinal and gastric cancerFRITSCHE JENS·Filed 2011·Granted Aug 11, 2015·46 cites·23 claims
- 1697US11975042B2Immunotherapy against several tumors including gastrointestinal and gastric cancerIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted May 7, 2024·2 cites·21 claims
- 1797US11883462B2Immunotherapy against several tumors including gastrointestinal and gastric cancerIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Jan 30, 2024·2 cites·20 claims
- 1897US11850274B2Immunotherapy against several tumors including gastrointestinal and gastric cancerIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Dec 26, 2023·2 cites·20 claims
- 1997US11839643B2Immunotherapy against several tumors including gastrointestinal and gastric cancerIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Dec 12, 2023·2 cites·20 claims
- 2097US10434136B2Powerful MHC-class II peptides derived from survivinIMMATICS BIOTECHNOLOGIES GMBH·Filed 2013·Granted Oct 8, 2019·47 cites·3 claims
- 2197US7994276B2Composition of tumour-associated peptides and related anti-cancer vaccineIMMATICS BIOTECHNOLOGIES GMBH·Filed 2008·Granted Aug 9, 2011·30 cites·22 claims
- 2296US9498512B2Powerful MHC-class II peptides derived from survivinRAMMENSEE HANS-GEORG·Filed 2012·Granted Nov 22, 2016·56 cites·5 claims
- 2396US8647629B2Powerful MHC-class II peptides derived from survivinRAMMENSEE HANS-GEORG·Filed 2009·Granted Feb 11, 2014·56 cites·8 claims
- 2495US9132177B2Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of gastric cancer and other cancersFRITSCHE JENS·Filed 2011·Granted Sep 15, 2015·19 cites·10 claims
- 2594US10159725B2Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of gastric cancer and other cancersFRITSCHE JENS·Filed 2011·Granted Dec 25, 2018·13 cites·4 claims
- 2694US9289478B2Formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or class II molecules for vaccineLEWANDROWSKI PETER·Filed 2009·Granted Mar 22, 2016·46 cites·16 claims
- 2794US9023804B2HLA-binding peptides derived from prostate-associated antigenic molecules and methods of use thereofWEINSCHENK TONI·Filed 2011·Granted May 5, 2015·12 cites·22 claims
- 2894US2025049886A1Novel immunotherapy against several tumors including gastrointestinal and gastric cancerIMMATICS BIOTECHNOLOGIES GMBH·Filed 2024·Application pending·0 cites
- 2993US11957729B2Powerful MHC-class II peptides derived from survivinIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Apr 16, 2024·4 cites·14 claims
- 3093US9283267B2Formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or class II molecules for vaccinesLEWANDROWSKI PETER·Filed 2012·Granted Mar 15, 2016·38 cites·17 claims
- 3184US12064465B2Immunotherapy against several tumors including gastrointestinal and gastric cancerIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Aug 20, 2024·0 cites·20 claims
- 3283US11969455B2Immunotherapy against several tumors including gastrointestinal and gastric cancerIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Apr 30, 2024·0 cites·21 claims
- 3383US11957730B2Immunotherapy against several tumors including gastrointestinal and gastric cancerIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Apr 16, 2024·0 cites·21 claims
- 3475US9023802B2HLA-binding peptides derived from prostate-associated antigenic molecules and methods of use thereofRAMMENSEE HANS GEORG·Filed 2010·Granted May 5, 2015·3 cites·20 claims
- 3571US2017304399A1Novel immunotherapy against several tumors including gastrointestinal and gastric cancerIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Application pending·0 cites
- 3661US2014086943A1Novel and powerful mhc-class ii peptides derived from survivinIMMATICS BIOTECHNOLOGIES GMBH·Filed 2013·Application pending·0 cites
- 3739US2011229505A1Methods for the diagnosis and treatment of cancer based on AVL9IMMATICS BIOTECHNOLOGIES GMBH·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →